Harel Insurance Investments & Financial Services Ltd. Dr Reddys Laboratories LTD Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.31 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$57.98 - $73.08 $23,192 - $29,232	-400 Closed	0 $0
Q4 2020 Jan 26, 2021	SELL	$62.61 - $71.29 $8,389 - $9,552	-134 Reduced 25.09%	400 $92,000
Q3 2020 Oct 20, 2020	BUY	$51.39 - $72.41 $27,442 - $38,666	534 New	534 $37,000

Others Institutions Holding RDY

# of Institutions

233

Shares Held

24M

Call Options Held

14.6K

Put Options Held

2.8K

Robeco Institutional Asset Management B.V.

2.07M
Shares

$164 Million
0.34% of portfolio
Royal Bank Of Canada Toronto, A6

2.06M
Shares

$163 Million
0.04% of portfolio
Morgan Stanley New York, NY

2.03M
Shares

$161 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2M
Shares

$159 Million
0.27% of portfolio
Black Rock Inc. New York, NY

1.8M
Shares

$143 Million
0.0% of portfolio

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account